Drimva

Legend Biotech

CQV Manager

$127K–$167K

Raritan, New Jersey, United States +1 · Manager · Full-time · Posted Oct 22, 2026

Location
Raritan, New Jersey, United States
United States
Experience
Minimum 8 years of progressive relevant experience and minimum 5 years of leadership or supervisory experience.
Education
Bachelor’s degree in engineering, Life Sciences, Pharmaceutical Sciences, Biotechnology, Chemistry, Microbiology, or related technical discipline.
Visa sponsorship
Applicants must be authorized to work in the United States. The company participates in E-Verify.

About the job

Leads commissioning, qualification, and validation programs for a cGMP cell therapy facility, keeping facilities, equipment, utilities, computerized systems, and manufacturing processes compliant and validated.

What you'll do

  • Oversee CQV and CSV projects, lifecycle documentation, qualification programs, and remediation activities.
  • Lead investigations, CAPAs, change controls, risk assessments, and audit or inspection readiness.
  • Coordinate cross-functional teams and vendors, and provide technical guidance to CQV personnel.

What they ask for

  • Bachelor’s degree in a relevant technical discipline.
  • At least 8 years of progressive experience in CQV/CSV, Quality, Engineering, Manufacturing, or Compliance in a regulated industry.
  • At least 5 years of leadership or supervisory experience.
  • Expertise in applicable FDA and global regulations, and experience with validation programs, inspections, investigations, CAPAs, and change controls.

Nice to have

  • Advanced degree or relevant professional certifications.
  • Aseptic manufacturing experience; cell therapy, CAR-T, biologics, tissue processing, quality assurance, or manufacturing compliance experience is highly desirable.

Pay

$127,313 — $167,099 USD (base pay)

Tools

Maximo, Siemens EMS, Comet, Kneat, Summit, Microsoft Office, Word, Excel

Model-written summary · the original posting is authoritative

First seen Oct 29, 2026 · Last verified Nov 5, 2026 (UTC)